Through gene therapy, researchers engineered blood-forming stem cells (hematopoietic stem/progenitor cells, or HSPCs) to carry chimeric antigen receptor (CAR) genes to make cells that can detect and destroy HIV-infected cells. These engineered cells not only destroyed the infected cells, they persisted for more than two years, suggesting the potential to create long-term immunity from the virus that causes AIDS.
Antiviral drugs can suppress the amount of HIV in the body to nearly undetectable levels, but only an effective immune response can eradicate the virus. Researchers have been seeking a way to improve the body’s ability to combat the virus by engineering blood-forming stem cells to specifically target and kill HIV-infected cells for the life of the individual. Although chimeric antigen receptor (CAR) T-cells have emerged as a powerful immunotherapy for various forms of cancer – and show promise in treating HIV-1 infection – the therapy may not impart long-lasting immunity. Researchers, physicians and patients need T cell-based products that can respond to malignant or infected cells that may reappear months or years after treatment.
Because HIV uses CD4 to infect cells, the researchers used a CAR molecule that hijacks the essential interaction between HIV and the cell surface molecule CD4 to make stem cell-derived T-cells target infected cells. When the CD4 on the CAR molecule binds to HIV, other regions of the CAR molecule signal the cell to become activated and kill the HIV infected cell. The researchers found that, in test animals, modification of the blood-forming stem cells resulted in more than two years of stable production of CAR-expressing cells without any adverse effects. In addition, these cells were widely distributed throughout the lymphoid tissues and gastrointestinal tract, which are major anatomic sites for HIV replication and persistence in infected people. Most important, engineered CAR T-cells showed efficacy in attacking and killing HIV-infected cells.
These findings are the first to show that blood-forming stem cells can be modified with a CAR therapy that can safely engraft in the bone marrow, mature and become functional immune cells throughout the body. This could lead to the development of an approach allowing for safe, lifelong immunity to HIV. Such an approach is likely to work best when performed in combination with other treatment strategies, such as antiretroviral therapy. Researchers hope that this type of therapy could reduce infected individuals’ dependence on antiviral medications, lower the cost of therapy, and permit the possible eradication of HIV from its hiding places in the body. The approach also has potential against other infections or malignancies.
The Latest on: HIV gene therapy
- We must strictly regulate gene-editing now, before it becomes the norm on February 19, 2019 at 7:45 am
Dr. He Jiankui conducted the research, in which the genes of twins were edited to resist HIV infections; it has created a scientific ... which is the focus of a half-dozen clinical trials using gene t... […]
- Putting the interests of patients first on February 15, 2019 at 6:30 pm
HIV, mental illness and other serious conditions. Having served on the health subcommittee in Congress for many years, it’s clear to me change is happening swiftly — perhaps too swiftly. Let’s conside... […]
- Gene Therapy Market Growth 2019-2024 by Research Companies-Bluebird Bio, Sangamom, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio and More on February 14, 2019 at 12:47 am
Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approac... […]
- Gene therapy Market Size 2019 Analytical Overview, Growth Factors, Demand and Trends Forecast to 2024 on February 12, 2019 at 9:28 am
Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson’s disease, cancer and even HIV, through a number of different approac... […]
- Many people are confused and concerned about human gene editing. They might just need a ‘better understanding’ of how it works on February 12, 2019 at 5:56 am
He revealed that he had gene-edited two babies at the instant that sperm met eggs to engineer resistance to HIV infection, announced via YouTube on November 25, 2017. It was a proof-of-principle ... […]
- Gene therapy could eliminate drug side effect in Parkinson’s patients on January 11, 2019 at 10:45 am
A Michigan State University researcher has received a $2.8 million federal grant to develop a gene therapy that could reduce and possibly ... Faulty immune receptor could be reason why many face HIV c... […]
- Russian research institute develops new HIV medicine on April 20, 2018 at 7:47 pm
The Russian Central Research Institute of Epidemiology has developed a new gene therapy medicine for people who have the HIV, head of the federal health and epidemic watchdog Rospotrebnadzor, Anna Pop... […]
- Sangamo’s Gain, Gilead’s Loss? HIV Treatment Outlook Buoyed by Gene Therapy on March 9, 2018 at 4:00 pm
As the news emerged of Richmond, CA-based Sangamo Biosciences’s progress toward a gene therapy treatment for HIV infection, the media buzzed and investors boosted the company’s share price by 17 perce... […]
- Can gene therapy be harnessed to fight the HIV virus? on February 13, 2018 at 4:57 am
For more than a decade, the strongest AIDS drugs could not fully control Matt Chappell’s HIV infection. Now his body controls it by itself, and researchers are trying to perfect the gene editing that ... […]
- Can gene therapy be harnessed to fight the AIDS virus? on February 12, 2018 at 11:19 pm
Now researchers think they can improve the treatment and are trying again to tackle HIV by doctoring DNA. New studies to test these tweaked approaches in people are getting underway. "Gene therapy tec... […]
via Google News and Bing News